New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 2, 2014
08:35 EDTSMEDSharps Compliance settles government contract termination lawsuit
Sharps Compliance announced that the company has entered into an agreement settling all claims against the United States government and various agencies related to the January 2012 termination of the Company's February 2009 contract with the Centers for Disease Control and Prevention. The settlement agreement calls for a cash payment to Sharps Compliance of $1.54M, which is inclusive of interest. Each party will bear its own costs, attorney fees, and expenses. The settlement amount is expected to be received over the next 30 to 60 days and will be recorded as a recovery of previously incurred post-contract termination expenses. The settlement will have a positive net income impact of 10c per share.
News For SMED From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
15:25 EDTSMEDNew York confirms health care worker being tested for Ebola
Subscribe for More Information
14:58 EDTSMEDNew York doctor rushed to hospital with Ebola-like symptoms, NY Post reports
Subscribe for More Information
06:22 EDTSMEDEU to boost Ebola research with EUR 24.4M
The European Commission has today announced EUR 24.4M from the EU budget for urgently needed Ebola research. The funding will go to five projects, ranging from a large-scale clinical trial of a potential vaccine, to testing existing and novel compounds to treat Ebola. The money from Horizon 2020, the EU research and innovation program, will be provided via a fast-track procedure in order to start work as soon as possible. The Commission is also working with industry on the further development of vaccines, drugs and diagnostics for Ebola and other haemorrhagic diseases within the Innovative Medicines Initiative. The funding will be provided following proposals from teams across the EU and in numerous 3rd countries, which were evaluated by an independent group of experts. The Commission has also asked the European and Developing Countries Clinical Trials Partnership to include emerging epidemics of concern to Africa, including Ebola, in its work plan. This will allow to fund clinical trials on drugs, vaccines and diagnostics in upcoming calls. Drug companies that are working on experimental Ebola vaccines or treatments include Peregrine (PPHM), Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Some companies that offer protective clothing and waste disposal include Lakeland Industries (LAKE), Alpha Pro Tech (APT) and Sharps Compliance (SMED).
October 22, 2014
06:54 EDTSMEDProtection equipment makers see sales rise amid Ebola situation, NY Times says
Subscribe for More Information
October 17, 2014
09:46 EDTSMEDSarepta soars after publication of Ebola drug candidate data
Subscribe for More Information
October 15, 2014
10:49 EDTSMEDEbola linked names rise again amid broader market sell-off
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use